The Laboratory-based Epidemiological Surveillance Office is responsible for the coordination and implementation of the Laboratory-based Epidemiological Surveillance System, which monitors the laboratory results of clinical specimens taken from infectious diseases patients. The pathogens monitored by the system are: Salmonella spp. Shigella spp., STEC, Campylobacter spp., Yersinia enterocolitica, Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, Streptococcus pneumoniae, Brucella spp., Legionella pneumophila, Rotavirus, Adenovirus, Norovirus, Rubella virus, Hepatitis A virus, and Toxoplasma gondii.
The aims of the Laboratory-based Surveillance are the following:
The laboratories of public hospitals and private diagnostic centers participate in the pilot phase of the system, which was initiated in February 2012. The number of the participating sites is gradually increasing until it reaches a sufficient number, which is representative of the geographical and population distribution of the target population of the country.
The data are maintained in an electronic database built with the use of Epi-Info software of the U.S.A. Centers for Diseases Control and Prevention.
HCDCP personnel conduct on-site visits to the participating hospitals and diagnostic centers and train health professionals in implementing the laboratory-based surveillance system.
The analysis will be performed on a weekly basis and it will include (i) analysis of trends over time for the frequency of detection of pathogens of interest, (ii) the geographic depiction of the frequency, and (iii) stratified analysis by age, gender, nationality and by other factors included in the notification forms.
|Angeliki Lambrou||Office Manager||210 8899024|
|Ioanna Kokkali||Administrative officer||210 8899025|